Gilead Sciences, Inc. · NASDAQ:GILD
Berger Dietmar exercised options for 533 Gilead Sciences, Inc. shares (Form 4)
Traded Sep 10, 2026 · Filed Sep 11, 2026
On Sep 10, 2026, Berger Dietmar (Chief Medical Officer) exercised options for 533 Gilead Sciences, Inc. shares, leaving 19,522 shares. Filed Sep 11, 2026 (Form 4).
- Options exercised
- 533 shares
- Holding after
- 19,522 shares
- Trading plan
- No
- Role
- Chief Medical Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 10, 2026 | Common Stock | Option exercise | 533 | 19,785 | Direct | |
| Sep 10, 2026 | Common Stock | Shares withheld for tax | 263 | US$144.81 | 19,522 | Direct |
Source
Related
- Gilead Sciences, Inc.
- Berger Dietmar
- Gilead Sciences, Inc. shareholders
- Form 4 · Berger Dietmar · Jun 11, 2026
- Form 4 · Mercier Johanna · Oct 16, 2026
- Form 4 · Dickinson Andrew D · Oct 16, 2026
- Form 4 · O'Day Daniel Patrick · Oct 2, 2026
- Form 4 · Burkhart Erin · Sep 23, 2026
- Form 4 · Mercier Johanna · Sep 16, 2026